Efficacy of Traditional Chinese Medicine on Animal Model of IgA Nephropathy: A Systematic Review and Meta-Analysis
暂无分享,去创建一个
[1] Shen Li,et al. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial , 2020, Trials.
[2] J. Barratt,et al. IgA nephropathy: "State of the art": a report from the 15th International Symposium on IgA Nephropathy celebrating the 50th anniversary of its first description. , 2019, Kidney international.
[3] David W. Johnson,et al. Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. , 2019, Kidney international.
[4] F. Schena,et al. Epidemiology of IgA Nephropathy: A Global Perspective. , 2018, Seminars in nephrology.
[5] Xuefeng Sun,et al. Abelmoschus manihot – a traditional Chinese medicine versus losartan potassium for treating IgA nephropathy: study protocol for a randomized controlled trial , 2017, Trials.
[6] C. Pozzi. Treatment of IgA nephropathy , 2016, Journal of Nephrology.
[7] J. He,et al. Recent Advances in Traditional Chinese Medicine for Kidney Disease. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[8] Krzysztof Kiryluk,et al. The genetics and immunobiology of IgA nephropathy. , 2014, The Journal of clinical investigation.
[9] K. Nitta,et al. Prognosis in IgA Nephropathy: 30-Year Analysis of 1,012 Patients at a Single Center in Japan , 2014, PloS one.
[10] Yusuke Suzuki,et al. Development of Animal Models of Human IgA Nephropathy. , 2014, Drug discovery today. Disease models.
[11] Gordon H Guyatt,et al. GRADE guidelines: 9. Rating up the quality of evidence. , 2011, Journal of clinical epidemiology.
[12] P. Tan,et al. Global Evolutionary Trend of the Prevalence of Primary Glomerulonephritis over the Past Three Decades , 2010, Nephron Clinical Practice.
[13] Masahiko Ando,et al. A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[14] Gang Liu,et al. The changing spectrum of primary glomerular diseases within 15 years: a survey of 3331 patients in a single Chinese centre. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[15] S. Hubchak,et al. TGF-β signal transduction and mesangial cell fibrogenesis , 2003 .
[16] I. T. Ten Berge,et al. What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis? , 2001, Kidney international.
[17] M. Rastaldi,et al. Idiopathic IgA nephropathy with segmental necrotizing lesions of the capillary wall. , 2001, Kidney international.
[18] M. Ketteler,et al. TGF-beta: a cytokine mediator of glomerulosclerosis and a target for therapeutic intervention. , 1995, Kidney international. Supplement.
[19] J. Berger,et al. [Intercapillary deposits of IgA-IgG]. , 1968, Journal d'urologie et de nephrologie.
[20] Zhang Zhijian,et al. Experimental Study on Artemisinin Combined with Hydroxychloroquine in Treating Rats with IgA Nephropathy , 2016 .
[21] Wang Shengzhi. Effects of Qijishenkang Granule on Renal Tissue of IL-13 and CIC From Serum of Rats with IgA Nephropathy , 2013 .
[22] Guo Deng-zhou,et al. Influences of Shenyanning on renal signal pathway of TGF-β_1 and p38MAPK in rats with IgA nephropathy , 2010 .
[23] Yuan Chun-l. Expression of MMP-9 and TIMP-1 in Non-Small-Cell Lung Cancer and its Relationship with Clinical Pathological Features , 2009 .
[24] Huang Guo-dong. The Expression of Compound Xiancao Capsule on IL-6 TNF-α of IgA Nephropathy Tissue , 2009 .
[25] Guo Dengzhou. Effect of Shenyanning on the correlation factors of the inflammation reaction in renal tissue of IgA nephropathy rats , 2009 .
[26] F. Qi. Establishment of IgAN Model in Rats and Determination of the Serum IL-6,FN and NO , 2008 .
[27] Zeng Lin. Study on the Effects of Qilianmaogentang on the Experimental IgA Nephropathy Rat , 2006 .
[28] Wang Gang. Effects of Jianshen Tablet on Renal Expression of TGF-β_1 in Rats with IgAN , 2004 .
[29] Zhou Jiajun. The Study of Gubentongluochongji on Experimental IgA Nephropathy , 2003 .
[30] Junwei Yang,et al. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. , 2003, The Journal of clinical investigation.
[31] S. Hubchak,et al. TGF-beta signal transduction and mesangial cell fibrogenesis. , 2003, American journal of physiology. Renal physiology.
[32] N. Yorioka,et al. Localization of Transforming Growth Factors ß1 and ß2 and Epidermal Growth Factor in IgA Nephropathy , 1999 .
[33] P. Zucchelli,et al. [IgA nephropathy]. , 1985, Medicina clinica.